Connect with us

Hi, what are you looking for?

Artificial Intelligence

FDA Offers Expanded Clearance for DreaMed’s AI-Based Support System for Type 2 Diabetes

DreaMed’s platform leverages the power of artificial intelligence (AI) to optimize insulin administration.

FDA Offers Expanded Clearance for DreaMed’s AI-Based Support System for Type 2 Diabetes

DreaMed Diabetes AI announced today that it received FDA clearance that expands its platform’s target population to cover type 1 and type 2 diabetes.

Tel Aviv, Israel-based DreaMed’s Advisor Pro AI clinical decision support system assists healthcare providers in the management of diabetes patients who use insulin pumps or injections and monitor their glucose using a continuous glucose monitor (CGM) and/or blood glucose meters.

DreaMed’s platform leverages the power of artificial intelligence (AI) to optimize insulin administration. The latest expanded clearance represents the fourth from the FDA for the platform, according to a news release.

The platform also received CE mark and had FDA clearance for people with type 1 diabetes. It is already deployed across leading diabetes treatment centers, including Yale New Haven Health, Texas Children’s Hospital, Unviersity of Florida and more.

”There are simply not enough endocrinologists to provide the expert level care that all people with diabetes require continuously,” DreaMed founder & CEO Eran Atlas said in the release. “DreaMed empowers the medical staff to treat significantly more patients by providing access to expert endocrinological advice in primary care settings. We can potentially help avoid thousands of unnecessary hospitalizations and medical complications for the community of people with diabetes and change the overall standards of care in this sector.

“The FDA clearance puts us on a path to help millions of people with diabetes and our next step is to develop and extend our solution to cover all injectable or oral medications for diabetes.”

Seen on Drug Delivery Business: Article Link

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Latest News

Artificial Intelligence

The agency says stakeholders can use the principles to tailor and adopt good practices from other sectors to be used in the health tech...

Artificial Intelligence

The platform is ultimately meant to help accelerate clinical trials and increase the probability of success of future therapies for Parkinson’s, Alzheimer’s, Multiple Sclerosis,...

Diagnostics

An Edinburgh researcher working on new therapies for difficult-to-treat cancers has become one of the first recipients of $20m worth of funding from an...

Digital Health

A freelance scientist from online platform Kolabtree has supported medical start-up Aires Medical with the development of a new oxygen concentrator.

You May Also Like

Artificial Intelligence

Digital Solutions In Healthcare Plug “digital healthcare solutions” into Google, and the results are clear: digital tools have taken the healthcare industry by storm....

COVID-19

In Delray Beach, Florida, an emerging biopharma company, Cyrano Therapeutics, is planning a clinical trial using approved theophylline via a new intranasal pathway of...

Artificial Intelligence

Joe Mullings discusses the Microbot – Liberty robotic platform with Harel Gadot and how a new category of surgical robotics creates a new entry...

Digital Health

Software as a Medical Device (SaMD) is driving innovation in the HealthTech space and is more popular than ever — completely upending the way...